Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothe...InSilico Medicine
Loss of sSJ proteins causes persistent apical aPKC in intestinal progenitor cells and promotes stem cell overproliferati...National Institutes of Natural Sciences
Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Adv...InSilico Medicine
